Connection

ANAIS MALPICA to Endometrial Neoplasms

This is a "connection" page, showing publications ANAIS MALPICA has written about Endometrial Neoplasms.
Connection Strength

5.473
  1. Prophylactic Risk-reducing Hysterectomies and Bilateral Salpingo-oophorectomies in Patients With Lynch Syndrome: A Clinicopathologic Study of 29 Cases and Review of the Literature. Int J Gynecol Pathol. 2020 Jul; 39(4):313-320.
    View in: PubMed
    Score: 0.381
  2. Mesonephric-like Carcinoma of the Endometrium: A Subset of Endometrial Carcinoma With an Aggressive Behavior. Am J Surg Pathol. 2020 04; 44(4):429-443.
    View in: PubMed
    Score: 0.375
  3. Gynaecological malignancies and sentinel lymph node mapping: an update. Histopathology. 2020 Jan; 76(1):139-150.
    View in: PubMed
    Score: 0.368
  4. Ultrastaging of Sentinel Lymph Nodes in Endometrial Carcinoma According to Use of 2 Different Methods. Int J Gynecol Pathol. 2018 May; 37(3):242-251.
    View in: PubMed
    Score: 0.328
  5. Undifferentiated Carcinoma of the Endometrium: An Expanded Immunohistochemical Analysis Including PAX-8 and Basal-Like Carcinoma Surrogate Markers. Int J Gynecol Pathol. 2016 Sep; 35(5):410-8.
    View in: PubMed
    Score: 0.292
  6. Neuroendocrine Carcinoma of the Endometrium: A Clinicopathologic Study of 25 Cases. Am J Surg Pathol. 2016 May; 40(5):577-86.
    View in: PubMed
    Score: 0.286
  7. How to approach the many faces of endometrioid carcinoma. Mod Pathol. 2016 Jan; 29 Suppl 1:S29-44.
    View in: PubMed
    Score: 0.279
  8. Endometrioid stromal sarcoma: a clinicopathologic study of 63 cases. Am J Surg Pathol. 2013 Nov; 37(11):1635-47.
    View in: PubMed
    Score: 0.240
  9. Lymph node counts in endometrial cancer: expectations versus reality. Am J Surg Pathol. 2011 Jun; 35(6):913-8.
    View in: PubMed
    Score: 0.203
  10. Nodal endosalpingiosis in ovarian serous tumors of low malignant potential with lymph node involvement: a case for a precursor lesion. Am J Surg Pathol. 2010 Oct; 34(10):1442-8.
    View in: PubMed
    Score: 0.194
  11. Undifferentiated carcinoma of the endometrium: a review. Pathology. 2007 Feb; 39(1):134-8.
    View in: PubMed
    Score: 0.150
  12. Association of low-grade endometrioid carcinoma of the uterus and ovary with undifferentiated carcinoma: a new type of dedifferentiated carcinoma? Int J Gynecol Pathol. 2006 Jan; 25(1):52-8.
    View in: PubMed
    Score: 0.140
  13. Extrauterine Mesonephric-like Carcinoma: A Comprehensive Single Institution Study of 33 Cases. Am J Surg Pathol. 2023 06 01; 47(6):635-648.
    View in: PubMed
    Score: 0.115
  14. Calcifications in ovary and endometrium and their neoplasms. Mod Pathol. 2003 Mar; 16(3):219-22.
    View in: PubMed
    Score: 0.115
  15. SOX17: A Highly Sensitive and Specific Immunomarker for Ovarian and Endometrial Carcinomas. Mod Pathol. 2023 02; 36(2):100001.
    View in: PubMed
    Score: 0.114
  16. Endometrial cancer recurrence at multiple port sites. Int J Gynecol Cancer. 2020 06; 30(6):893-896.
    View in: PubMed
    Score: 0.094
  17. International Society of Gynecological Pathologists (ISGyP) Endometrial Cancer Project: Guidelines From the Special Techniques and Ancillary Studies Group. Int J Gynecol Pathol. 2019 Jan; 38 Suppl 1:S114-S122.
    View in: PubMed
    Score: 0.086
  18. The International Society of Gynecological Pathologists (ISGyP) Endometrial Carcinoma Project. Int J Gynecol Pathol. 2019 Jan; 38 Suppl 1:S1-S2.
    View in: PubMed
    Score: 0.086
  19. Current Practices in the Processing, Diagnosis, and Reporting of Endometrial Carcinoma: Results of a Web-based Survey by the International Society of Gynecological Pathologists (ISGyP). Int J Gynecol Pathol. 2019 Jan; 38 Suppl 1:S3-S8.
    View in: PubMed
    Score: 0.086
  20. Endometrial Carcinoma, Grossing and Processing Issues: Recommendations of the International Society of Gynecologic Pathologists. Int J Gynecol Pathol. 2019 Jan; 38 Suppl 1:S9-S24.
    View in: PubMed
    Score: 0.086
  21. Issues in the Differential Diagnosis of Uterine Low-grade Endometrioid Carcinoma, Including Mixed Endometrial Carcinomas: Recommendations from the International Society of Gynecological Pathologists. Int J Gynecol Pathol. 2019 Jan; 38 Suppl 1:S25-S39.
    View in: PubMed
    Score: 0.086
  22. High-grade Endometrial Carcinomas: Morphologic and Immunohistochemical Features, Diagnostic Challenges and Recommendations. Int J Gynecol Pathol. 2019 Jan; 38 Suppl 1:S40-S63.
    View in: PubMed
    Score: 0.086
  23. Endometrial Carcinoma Diagnosis: Use of FIGO Grading and Genomic Subcategories in Clinical Practice: Recommendations of the International Society of Gynecological Pathologists. Int J Gynecol Pathol. 2019 Jan; 38 Suppl 1:S64-S74.
    View in: PubMed
    Score: 0.086
  24. Guidelines to Aid in the Distinction of Endometrial and Endocervical Carcinomas, and the Distinction of Independent Primary Carcinomas of the Endometrium and Adnexa From Metastatic Spread Between These and Other Sites. Int J Gynecol Pathol. 2019 Jan; 38 Suppl 1:S75-S92.
    View in: PubMed
    Score: 0.086
  25. Pathologic Prognostic Factors in Endometrial Carcinoma (Other Than Tumor Type and Grade). Int J Gynecol Pathol. 2019 Jan; 38 Suppl 1:S93-S113.
    View in: PubMed
    Score: 0.086
  26. Vascular invasion in uterine sarcomas and its significance. A multi-institutional study. Hum Pathol. 2015 Nov; 46(11):1712-21.
    View in: PubMed
    Score: 0.068
  27. Low-stage clear-cell carcinoma of the endometrium. Am J Surg Pathol. 1995 Jul; 19(7):769-74.
    View in: PubMed
    Score: 0.067
  28. Risk factor analysis of recurrence in low-grade endometrial adenocarcinoma. Hum Pathol. 2015 Oct; 46(10):1529-39.
    View in: PubMed
    Score: 0.067
  29. Risk factors for recurrence and prognosis of low-grade endometrial adenocarcinoma; vaginal versus other sites. Int J Gynecol Pathol. 2014 May; 33(3):268-73.
    View in: PubMed
    Score: 0.062
  30. The pattern of myometrial invasion as a predictor of lymph node metastasis or extrauterine disease in low-grade endometrial carcinoma. Am J Surg Pathol. 2013 Nov; 37(11):1728-36.
    View in: PubMed
    Score: 0.060
  31. Can proliferation biomarkers reliably predict recurrence in World Health Organization 2003 defined endometrial stromal sarcoma, low grade? PLoS One. 2013; 8(10):e75899.
    View in: PubMed
    Score: 0.060
  32. Prognostic value of the diagnostic criteria distinguishing endometrial stromal sarcoma, low grade from undifferentiated endometrial sarcoma, 2 entities within the invasive endometrial stromal neoplasia family. Int J Gynecol Pathol. 2013 May; 32(3):299-306.
    View in: PubMed
    Score: 0.058
  33. Diagnostic and prognostic morphometric features in WHO2003 invasive endometrial stromal tumours. Histopathology. 2013 Apr; 62(5):688-94.
    View in: PubMed
    Score: 0.058
  34. Stages I to II WHO 2003-defined low-grade endometrial stromal sarcoma: how much primary therapy is needed and how little is enough? Int J Gynecol Cancer. 2013 Mar; 23(3):488-93.
    View in: PubMed
    Score: 0.057
  35. Biomarkers and microsatellite instability analysis of curettings can predict the behavior of FIGO stage I endometrial endometrioid adenocarcinoma. Mod Pathol. 2011 Sep; 24(9):1262-71.
    View in: PubMed
    Score: 0.051
  36. Molecular biomarkers in endometrial hyperplasias predict cancer progression. Am J Obstet Gynecol. 2011 Apr; 204(4):357.e1-12.
    View in: PubMed
    Score: 0.050
  37. Endometrial endometrioid adenocarcinoma of the uterine corpus involving the cervix: some cases probably represent independent primaries. Int J Gynecol Pathol. 2010 Mar; 29(2):146-56.
    View in: PubMed
    Score: 0.047
  38. The significance of neuroendocrine expression in undifferentiated carcinoma of the endometrium. Int J Gynecol Pathol. 2009 Mar; 28(2):142-7.
    View in: PubMed
    Score: 0.043
  39. Vascular pseudoinvasion in laparoscopic hysterectomy specimens for endometrial carcinoma: a grossing artifact? Am J Surg Pathol. 2009 Feb; 33(2):298-303.
    View in: PubMed
    Score: 0.043
  40. Combined large cell neuroendocrine carcinoma and papillary serous carcinoma of the endometrium with pagetoid spread. Arch Pathol Lab Med. 2008 Nov; 132(11):1821-4.
    View in: PubMed
    Score: 0.042
  41. Thyroid transcription factor-1 expression in endometrial and endocervical adenocarcinomas. Am J Surg Pathol. 2007 Nov; 31(11):1759-63.
    View in: PubMed
    Score: 0.040
  42. Discordant genetic changes in ovarian and endometrial endometrioid carcinomas: a potential pitfall in molecular diagnosis. Int J Gynecol Cancer. 2006 Jan-Feb; 16(1):178-82.
    View in: PubMed
    Score: 0.035
  43. Undifferentiated carcinoma of the endometrium. Am J Surg Pathol. 2005 Oct; 29(10):1316-21.
    View in: PubMed
    Score: 0.034
  44. Differential expression of WT-1 in serous carcinomas in the peritoneum with or without associated serous carcinoma in endometrial polyps. Am J Surg Pathol. 2005 Aug; 29(8):1074-8.
    View in: PubMed
    Score: 0.034
  45. Endometrial hyperplasia and endometrial cancer. Obstet Gynecol Clin North Am. 1996 Jun; 23(2):411-56.
    View in: PubMed
    Score: 0.018
  46. Prolonged stabilization of progressive endometrial stromal sarcoma with prolonged oral etoposide therapy. Gynecol Oncol. 1995 Aug; 58(2):262-5.
    View in: PubMed
    Score: 0.017
  47. Uterine neoplasms in patients treated with tamoxifen. J Cell Biochem Suppl. 1995; 23:179-83.
    View in: PubMed
    Score: 0.016
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.